About Us

Since 2022

Clinical Research Unit (CRU) RSCM - Pioneering the Future of Precision Medicine

For decades, the "one-size-fits-all" medical approach has been the standard, but we know that every patient is unique. At CRU RSCM, we are leading a revolutionary shift toward precision medicine, where every diagnosis, therapy, and prevention strategy is tailored to each individual's genetic profile and unique characteristics.
  • Cutting-edge genomic research
  • Strategic biobank for medical discovery
  • Innovative precision medicine services

Years pioneering
precision medicine.

3 +

Our Vision

To create personalized healthcare where every diagnosis, therapy, and prevention strategy is specifically tailored to each individual's genetic profile, fundamentally improving healthcare services for every patient.

Our Mission

Bridging advanced genomic research and patient care through an integrated innovation engine: cutting-edge research, strategic biobank, and innovative clinical services that bring real benefits directly to patients.

Our Commitment

Built on unwavering commitment to ethics, data confidentiality, and patient welfare. We maintain highest standards through informed consent, data anonymization, physical security, and strict ethical oversight.

OUR HISTORY

Our Journey in Clinical Research

2022

2022

BGSI Establishment

The Indonesian Ministry of Health established the Indonesian Genomic Science Center (BGSI).

National Hub Appointment

2022

National Hub Appointment

The MoH issued an official decree appointing Cipto Mangunkusumo Hospital (RSCM) as the national Hub for Metabolic Diseases.

ILPTKP

2023

ILPTKP Formation

In response, RSCM established the Translational Research and Precision Medicine Laboratory Unit (ILPTKP) to carry out activities under the Metabolic Disease Hub.

CRU

2024

CRU Transformation

ILPTKP was later renamed to the Clinical Research Unit (CRU).

Our Research

Cutting-edge Genomic Research

As the national metabolic disease hub designated by the Ministry of Health, our research focuses on Indonesia's most pressing health challenges using advanced genomic technologies and precision medicine approaches.
  • Youth diabetes genetic factors research
  • Familial hypercholesterolemia screening
  • Pharmacogenomics for personalized therapy
  • Indonesian population genomics study

100 %

Ethical compliance and patient privacy protection

1000 +

Biobank samples advancing medical research.

3

Main research pillars:
Genomics, Biobank, Clinical Trials

Join Us in advancing Indonesia's healthcare future Contact Us